Breathe Well Live Well
|
Spiriva Respimat Now Available in Pharmacies for Asthma Patients
Pharmacy Times “Despite taking other daily maintenance treatments, many people with asthma continue to experience symptoms, including coughing, wheezing, and shortness of breath,” said Michael Foggs, chief of allergy and immunology for the Advocate Medical Group at … |
View full post on asthma – Google News
Lung Disease News |
New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in US
Lung Disease News Boehringer Ingelheim Pharmaceuticals recently announced that SPIRIVA RESPIMAT, a new inhaled medicine for maintenance treatment of asthma, is now available by prescription in U.S. pharmacies for adults and adolescents. The U.S. Food and Drug … SPIRIVA® RESPIMAT® Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents |
View full post on asthma – Google News
|
SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents
Business Wire (press release) INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a … |
View full post on asthma – Google News
|
SPIRIVA ® RESPIMAT ® Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents
Business Wire (press release) INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a … SPIRIVA RESPIMAT Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents |
View full post on asthma – Google News
|
SPIRIVA RESPIMAT Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents
PR Newswire (press release) RIDGEFIELD, Conn., Feb. 3, 2016 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. today announced that SPIRIVA RESPIMAT is now available by prescription for the treatment of asthma in U.S. pharmacies. The U.S. Food and Drug … |
View full post on asthma – Google News
|
Spiriva Respimat Now Approved for Asthma
Pharmacy Times The FDA has added an asthma indication to Boehringer Ingelheim's tiotropium bromide inhalation spray (Spiriva Respimat). This long-acting muscarinic antagonist (LAMA) was originally approved in September 2014 for the maintenance treatment of chronic … FDA approves Spiriva Respimat for asthma in adults, adolescents |
View full post on asthma – Google News
|
FDA approves Spiriva Respimat for asthma in adults, adolescents
Healio “The [FDA] approval of Spiriva Respimat in asthma establishes a new class of inhaled asthma therapy and provides an efficacious, new option for patients,” William Mezzanotte, MD, MPH, said in the release. “There is extensive clinical evidence … |
View full post on asthma – Google News
European Pharmaceutical Review |
Spiriva Respimat (Tiotropium) Gets Asthma Indication in US
Medscape The US Food and Drug Administration (FDA) has approved the long-acting muscarinic antagonist tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim) for long-term maintenance treatment of asthma in people aged 12 years and older, according to a … FDA approves Boehringer's asthma treatment FDA approves asthma treatment Spiriva Respimat |
View full post on asthma – Google News
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: tiotropium; Device: Handihaler; Device: Respimat
Sponsor: University of Crete
Completed – verified January 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
FDA to review new drug application for Spiriva Respimat for asthma
Healio Boehringer Ingelheim Pharmaceuticals announced that the FDA has agreed to review its new drug application for tiotropium bromide inhalation spray for long-term maintenance of patients aged 12 years and older with asthma, according to a press release. Boehringer Ingelheim Announces U.S. Filing Acceptance of New Drug … |
View full post on asthma – Google News